In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens
Open Access
- 1 January 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (1), 173-175
- https://doi.org/10.1128/aac.34.1.173
Abstract
Norfloxacin- and ciprofloxacin-resistant mutants of several Enterobacter cloacae and Serratia marcescens isolates occurred at frequencies of greater than or equal to 10(-7)/CFU, which were higher than those of Escherichia coli isolates, in accordance with the increasing emergence of less-susceptible or resistant strains in clinical isolates of E. cloacae and S. marcescens.This publication has 14 references indexed in Scilit:
- Endogenous active efflux of norfloxacin in susceptible Escherichia coliAntimicrobial Agents and Chemotherapy, 1988
- The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivoJournal of Antimicrobial Chemotherapy, 1987
- Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12Antimicrobial Agents and Chemotherapy, 1986
- Genetic and biochemical characterization of norfloxacin resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 1986
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985
- Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classesAntimicrobial Agents and Chemotherapy, 1984
- In vitro and in vivo antibacterial activity of AT-2266Antimicrobial Agents and Chemotherapy, 1983
- Emergence of Resistance During Therapy with the Newer -Lactam Antibiotics: Role of Inducible -Lactamases and Implications for the FutureClinical Infectious Diseases, 1983
- Role of porin proteins OmpF and OmpC in the permeation of beta-lactamsAntimicrobial Agents and Chemotherapy, 1982
- Outer membrane permeation of beta-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacaeAntimicrobial Agents and Chemotherapy, 1982